Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2400 Pratt St
Durham, NC 27705Phone+1 919-668-1027- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1987 - 1990
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1986
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1983
Certifications & Licensure
- CA State Medical License 1987 - Present
- NC State Medical License 1996 - 2024
- VA State Medical License 2003 - 2006
- TN State Medical License 1984 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
- Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsA Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.Chenyu Lin, Rachel A DiCioccio, Tarek Haykal, William C McManigle, Zhiguo Li, Sarah M Anand, Jonathan C Poe, Sonali J Bracken, Wei Jia, Edwin P Alyea 3rd, Adela R Card...> ;Transplantation and Cellular Therapy. 2023 Mar 1
- 6 citationsPhase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.Yubin Kang, Pasupathi Sundaramoorthy, Cristina Gasparetto, Daniel Feinberg, Shengjun Fan, Gwynn Long, Emily Sellars, Anderson Garrett, Sascha A Tuchman, Brandi N Reeve...> ;Annals of Hematology. 2023 Feb 1
- 1 citationsRevisiting a single day salvage conditioning following graft failure.Emmanuel Katsanis, Therese Hennig, Jacob E Robinson, Gwynn Long, Nelson Chao, Mitchell Horwitz, David Rizzieri> ;Bone Marrow Transplantation. 2022 Dec 1
- Join now to see all
Abstracts/Posters
- Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell TransplantationGwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...Gwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell TransplantationGwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Hospital Affiliations
- Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: